Gut microbial communities are likely remodeled in tandem with accumulated physiological decline during aging,yet there is limited understanding of gut microbiome variation in advanced age.Here,we performed a metagenom...Gut microbial communities are likely remodeled in tandem with accumulated physiological decline during aging,yet there is limited understanding of gut microbiome variation in advanced age.Here,we performed a metagenomics-based enterotype analysis in a geographically homogeneous cohort of 367 enrolled Chinese individuals between the ages of 60 and 94 years,with the goal of characterizing the gut microbiome of elderly individuals and identifying factors linked to enterotype variations.In addition to two adult-like enterotypes dominated by Bacteroides(ET-Bacteroides)and Prevotella(ET-Prevotella),we identified a novel enterotype dominated by Escherichia(ET-Escherichia),whose prevalence increased in advanced age.Our data demonstrated that age explained more of the variance in the gut microbiome than previously identified factors such as type 2 diabetes mellitus(T2DM)or diet.We characterized the distinct taxonomic and functional profiles of ET-Escherichia,and found the strongest cohesion and highest robustness of the microbial co-occurrence network in this enterotype,as well as the lowest species diversity.In addition,we carried out a series of correlation analyses and co-abundance network analyses,which showed that several factors were likely linked to the overabundance of Escherichia members,including advanced age,vegetable intake,and fruit intake.Overall,our data revealed an enterotype variation characterized by Escherichia enrichment in the elderly population.Considering the different age distribution of each enterotype,these findings provide new insights into the changes that occur in the gut microbiome with age and highlight the importance of microbiome-based stratification of elderly individuals.展开更多
A total of 64 patients with acute lacunar infarction were enrolled within 24 hours of onset. The patients received conventional therapy （antiplatelet drugs and hypolipidemic drugs） alone or conventional therapy plus...A total of 64 patients with acute lacunar infarction were enrolled within 24 hours of onset. The patients received conventional therapy （antiplatelet drugs and hypolipidemic drugs） alone or conventional therapy plus 450 mg Xueshuantong once a day. The main ingredient of the Xueshuantong lyophilized powder used for injection was Panax notoginseng saponins. Assessments were made at admission and at discharge using the National Institutes of Health Stroke Scale, the Activity of Daily Living and the Mini-Mental State Examination. Additionally, the relative cerebral blood flow, relative cerebral blood volume and relative mean transit time in the region of interest were calculated within 24 hours after the onset of lacunar infarction, using dynamic susceptibility contrast magnetic resonance perfusion imaging technology. Patients underwent a follow-up MRI scan after 4 weeks of treatment. There was an improvement in the Activity of Daily Living scores and a greater reduction in the scores on the National Institutes of Health Stroke Scale in the treatment group than in the control group. However, the Mini-Mental State Examination scores showed no significant differences after 4 weeks of treatment. Compared with the control group, the relative cerebral blood flow at discharge had increased and showed a greater improvement in the treatment group. Furthermore, there was a reduction in the relative mean transit time at discharge and the value was lower in the treatment group than in the control group. The experimental findings indicate that Xueshuantong treatment improves neurological deficits in elderly patients with lacunar infarction, and the mechanism may be related to increased cerebral perfusion.展开更多
基金supported by the National Natural Science Foundation of China(Nos.82101665,82271588,82200665,and 82100795)the Zhejiang Provincial Natural Science Foundation of China(No.LY22H030009)+1 种基金the Zhejiang Provincial Science and Technology Program of Traditional Chinese Medicine(No.2023ZL480)the Medical and Health Research Project of Zhejiang Province(No.2023RC153),China.
文摘Gut microbial communities are likely remodeled in tandem with accumulated physiological decline during aging,yet there is limited understanding of gut microbiome variation in advanced age.Here,we performed a metagenomics-based enterotype analysis in a geographically homogeneous cohort of 367 enrolled Chinese individuals between the ages of 60 and 94 years,with the goal of characterizing the gut microbiome of elderly individuals and identifying factors linked to enterotype variations.In addition to two adult-like enterotypes dominated by Bacteroides(ET-Bacteroides)and Prevotella(ET-Prevotella),we identified a novel enterotype dominated by Escherichia(ET-Escherichia),whose prevalence increased in advanced age.Our data demonstrated that age explained more of the variance in the gut microbiome than previously identified factors such as type 2 diabetes mellitus(T2DM)or diet.We characterized the distinct taxonomic and functional profiles of ET-Escherichia,and found the strongest cohesion and highest robustness of the microbial co-occurrence network in this enterotype,as well as the lowest species diversity.In addition,we carried out a series of correlation analyses and co-abundance network analyses,which showed that several factors were likely linked to the overabundance of Escherichia members,including advanced age,vegetable intake,and fruit intake.Overall,our data revealed an enterotype variation characterized by Escherichia enrichment in the elderly population.Considering the different age distribution of each enterotype,these findings provide new insights into the changes that occur in the gut microbiome with age and highlight the importance of microbiome-based stratification of elderly individuals.
基金supported by the Technological Foundation Project of Traditional Chinese Medicine Science of Zhejiang Province,No.2012ZA077
文摘A total of 64 patients with acute lacunar infarction were enrolled within 24 hours of onset. The patients received conventional therapy （antiplatelet drugs and hypolipidemic drugs） alone or conventional therapy plus 450 mg Xueshuantong once a day. The main ingredient of the Xueshuantong lyophilized powder used for injection was Panax notoginseng saponins. Assessments were made at admission and at discharge using the National Institutes of Health Stroke Scale, the Activity of Daily Living and the Mini-Mental State Examination. Additionally, the relative cerebral blood flow, relative cerebral blood volume and relative mean transit time in the region of interest were calculated within 24 hours after the onset of lacunar infarction, using dynamic susceptibility contrast magnetic resonance perfusion imaging technology. Patients underwent a follow-up MRI scan after 4 weeks of treatment. There was an improvement in the Activity of Daily Living scores and a greater reduction in the scores on the National Institutes of Health Stroke Scale in the treatment group than in the control group. However, the Mini-Mental State Examination scores showed no significant differences after 4 weeks of treatment. Compared with the control group, the relative cerebral blood flow at discharge had increased and showed a greater improvement in the treatment group. Furthermore, there was a reduction in the relative mean transit time at discharge and the value was lower in the treatment group than in the control group. The experimental findings indicate that Xueshuantong treatment improves neurological deficits in elderly patients with lacunar infarction, and the mechanism may be related to increased cerebral perfusion.
